International Consensus (ICON): allergic reactions to vaccines

Abstract

BACKGROUND: Routine immunization, one of the most effective public health interventions, has effectively reduced death and morbidity due to a variety of infectious diseases. However, allergic reactions to vaccines occur very rarely and can be life threatening. Given the large numbers of vaccines administered worldwide, there is a need for an international consensus regarding the evaluation and management of allergic reactions to vaccines. METHODS: Following a review of the literature, and with the active participation of representatives from the World Allergy Organization (WAO), the European Academy of Allergy and Clinical Immunology (EAACI), the American Academy of Allergy, Asthma, and Immunology (AAAAI), and the American College of Allergy, Asthma, and Immunology (ACAAI), the final committee was formed with the purpose of having members who represented a wide-range of countries, had previously worked on vaccine safety, and included both allergist/immunologists as well as vaccinologists. RESULTS: Consensus was reached on a variety of topics, including: definition of immediate allergic reactions, including anaphylaxis, approaches to distinguish association from causality, approaches to patients with a history of an allergic reaction to a previous vaccine, and approaches to patients with a history of an allergic reaction to components of vaccines. CONCLUSIONS: This document provides comprehensive and internationally accepted guidelines and access to on-line documents to help practitioners around the world identify allergic reactions following immunization. It also provides a framework for the evaluation and further management of patients who present either following an allergic reaction to a vaccine or with a history of allergy to a component of vaccines.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 176

1. 1.
   Vaccines for the 21st century · 2014

   No notice
2. 2.

   Whitney CG, Zhou FJ, Singleton J, Schuchat A. Benefits from immunization during the vaccines for children program era - United States, 1994–2013. Mmwr-Morbid Mortal W. 2014;63(16):352-5.

   Not in our library

3. 3.

   Caubet JC, Ponvert C. Vaccine allergy. Immunol Allergy Clin North Am. 2014;34(3):597-613.

   Not in our library10.1016/j.iac.2014.04.004

4. 4.

   Kelso JM, Greenhawt MJ, Li JT, Nicklas RA, Bernstein DI, Blessing-Moore J, et al. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012;130(1):25-43.

   Not in our library10.1016/j.jaci.2012.04.003

5. 5.

   Vanlander A, Hoppenbrouwers K. Anaphylaxis after vaccination of children: review of literature and recommendations for vaccination in child and school health services in Belgium. Vaccine. 2014;32(26):3147-54.

   Not in our library10.1016/j.vaccine.2014.03.096

6. 6.

   Wood RA. Allergic reactions to vaccines. Pediatr Allergy Immunol. 2013;24(6):521-6.

   Not in our library10.1111/pai.12102

7. 7.

   RedBook. Red Book 2015: Report of the Committee on Infectious Diseases 30 ed. American Academy of Pediatrics; 2015.

   Not in our library

8. 8.

   Bohlke K, Davis RL, Marcy SM, Braun MM, DeStefano F, Black SB, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics. 2003;112(4):815-20.

   Not in our library10.1542/peds.112.4.815

9. 9.

   Zent O, Arras-Reiter C, Broeker M, Hennig R. Immediate allergic reactions after vaccinations--a post-marketing surveillance review. Eur J Pediatr. 2002;161(1):21-5.

   Not in our library10.1007/s00431-001-0853-0

10. 10.

    Erlewyn-Lajeunesse M, Hunt LP, Heath PT, Finn A. Anaphylaxis as an adverse event following immunisation in the UK and Ireland. Arch Dis Child. 2012;97(6):487-90.

    Not in our library10.1136/archdischild-2011-301163

11. 11.

    Cheng DR, Perrett KP, Choo S, Danchin M, Buttery JP, Crawford NW. Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013. Vaccine. 2015;33(13):1602-7.

    Not in our library10.1016/j.vaccine.2015.02.008

12. 12.

    Lotvall J, Pawankar R, Wallace DV, Akdis CA, Rosenwasser LJ, Weber RW, et al. We call for iCAALL: International Collaboration for Asthma, Allergy and Immunology. Ann Allergy Asthma Immunol. 2012;108(4):215-6.

    Not in our library10.1016/j.anai.2012.02.025

13. 13.

    Lotvall J, Pawankar R, Wallace DV, Akdis CA, Rosenwasser LJ, Weber RW, et al. We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology. J Allergy Clin Immunol. 2012;129(4):904-5.

    Not in our library10.1016/j.jaci.2012.02.009

14. 14.

    Lotvall J, Pawankar R, Wallace DV, Akdis CA, Rosenwasser LJ, Weber RW, et al. We call for iCAALL: International Collaboration in Asthma. Allergy Immunol Allergy. 2012;67(4):449-50.

    Not in our library10.1111/j.1398-9995.2012.02813.x

15. 15.

    Lotvall J, Pawankar R, Wallace DV, Akdis CA, Rosenwasser LJ, Weber RW, et al. We Call for iCAALL: International Collaboration in Asthma, Allergy and Immunology. World Allergy Organ J. 2012;5(3):39-40.

    Not in our library10.1097/wox.0b013e3182504245

16. 16.

    Kroger AT, Sumaya CV, Pickering LK, Atkinson WL. General recommendations on immunization. MMWR Recomm Rep. 2011;60(2):1-64.

    Not in our library

17. 17.

    Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56(9):813-24.

    Not in our library10.1034/j.1398-9995.2001.t01-1-00001.x

18. 18.
    International consensus on (ICON) anaphylaxis · 2014

    No notice
19. 19.

    Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391-7.

    Not in our library10.1016/j.jaci.2005.12.1303

20. 20.

    Ruggeberg JU, Gold MS, Bayas JM, Blum MD, Bonhoeffer J, Friedlander S, et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2007;25(31):5675-84.

    Not in our library10.1016/j.vaccine.2007.02.064

21. 21.

    Simons FE, Sampson HA. Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years). J Allergy Clin Immunol. 2015;135(5):1125-31.

    Not in our library10.1016/j.jaci.2014.09.014

22. 22.

    Simons FE, Sampson HA. Anaphylaxis epidemic: fact or fiction? J Allergy Clin Immunol. 2008;122(6):1166-8.

    Not in our library10.1016/j.jaci.2008.10.019

23. 23.

    Simons FE. Anaphylaxis pathogenesis and treatment. Allergy. 2011;66(Suppl 95):31-4.

    Not in our library10.1111/j.1398-9995.2011.02629.x

24. 24.

    Lee JM, Greenes DS. Biphasic anaphylactic reactions in pediatrics. Pediatrics. 2000;106(4):762-6.

    Not in our library10.1542/peds.106.4.762

25. 25.

    Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol. 2005;95(3):217-26.

    Not in our library10.1016/s1081-1206(10)61217-3

26. 26.

    Vinuya RZ, Simon MR, Schwartz LB. Elevated serum tryptase levels in a patient with protracted anaphylaxis. Ann Allergy. 1994;73(3):232-4.

    Not in our library

27. 27.

    Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026-45.

    Not in our library10.1111/all.12437

28. 28.

    Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30(8):1144-50.

    Not in our library10.1046/j.1365-2222.2000.00864.x

29. 29.

    Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol. 2010;126(3):477-80 e1-42.

    Not in our library10.1016/j.jaci.2010.06.022

30. 30.

    Cheifetz A, Smedley M, Martin S, Reiter M, Leone G, Mayer L, et al. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol. 2003;98(6):1315-24.

    Not in our library10.1111/j.1572-0241.2003.07457.x

31. 31.

    Brown SGA, Kemp SF, Lieberman PL, Adkinson NF, Bochner BS. Anaphylaxis. Middleton's Allergy: Principles and Practice. 2014;1237-59.

    Not in our library

32. 32.

    Buettcher M, Heininger U, Braun M, Bonhoeffer J, Halperin S, Heijbel H, et al. Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation. Vaccine. 2007;25(31):5875-81.

    Not in our library10.1016/j.vaccine.2007.04.061

33. 33.

    Centers for Disease C, Prevention. Syncope after vaccination--United States, January 2005-July 2007. MMWR Morb Mortal Wkly Rep. 2008;57(17):457-60.

    Not in our library

34. 34.

    Statement regarding interim findings of WHO assessment of deaths of children in Idleb Governorate, Syria. http://www.emro.who.int/entity/vpi/index.html. Accessed Aug 2016.

    Not in our library

35. 35.

    Sood DK, Kumar S, Singh S, Sokhey J. Adverse reactions after measles vaccination in India. Natl Med J India. 1995;8(5):208-10.

    Not in our library

36. 36.

    Orr P. Supplementary statement for the 2002–2003 influenza season: update on oculo-respiratory syndrome in association with influenza vaccination. Can Commun Dis Rep. 2002;28(ACS-6):1.

    Not in our library

37. 37.

    De Serres G, Toth E, Menard S, Grenier JL, Roussel R, Tremblay M, et al. Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons. Vaccine. 2005;23(28):3726-32.

    Not in our library10.1016/j.vaccine.2005.01.154

38. 38.

    Skowronski DM, Strauss B, De Serres G, MacDonald D, Marion SA, Naus M, et al. Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event? Clin Infect Dis. 2003;36(6):705-13.

    Not in our library10.1086/367667

39. 39.

    Stratton KR, Howe CI, Johnston RB. Adverse events associated with childhood vaccines: evidence bearing on causality. 1994.

    Not in our library

40. 40.

    Gold MS, Gidudu J, Erlewyn-Lajeunesse M, Law B, Brighton Collaboration Working Group on A. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study. Vaccine. 2010;28(28):4487-98.

    Not in our library10.1016/j.vaccine.2010.04.041

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.